Analyst Price Target is $13.88
▲ +47.76% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Clarivate in the last 3 months. The average price target is $13.88, with a high forecast of $15.00 and a low forecast of $12.00. The average price target represents a 47.76% upside from the last price of $9.39.
Current Consensus is
The current consensus among 5 investment analysts is to buy stock in Clarivate. This rating has held steady since August 2022, when it changed from a Hold consensus rating.
Clarivate Plc engages in the provision of global information, analytics, and workflow solutions. It operates through the following segments: Academia and Government (A&G), Life Sciences and Healthcare (LS&H), and Intellectual Property (IP). The A&G segment consists of products and services to organizations that plan, fund, implement, and utilize education and research at a global, national, institutional, and individual level. The LS&H segment comprises of products and solutions that provide insight and foresight across the drug and device lifecycle, empowering life science and healthcare organizations. The IP segment refers to patent intelligence, brand IP Intelligence, and IP Lifecycle Management product groups, which enables customers to establish, protect, and manage their intellectual property and form critical business decision while also mitigating risk and improving efficiencies. The company was founded in 1864 and is headquartered in London, the United Kingdom.